Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-24-114422

Chief Financial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-10-11 Exercise or conversion : show line 1 in the form +25,000 $2.48 $62,000 44,777 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-11 Exercise or conversion : show line 2 in the form Share Option (right to buy) −25,000 0 D
Loading xslF345X05/ownership.xml…